Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 54 entries
View as:

Evaluating the Safety, Tolerability, and Pharmacokinetics of BAT1006

Phase: N/A Priority: Normal
NCT ID: NCT05414136 Org: User:
Start: 02/10/22 End: 06/17/24 Due: 06/17/25

BAT7104 Injection in Patients with Advanced Malignant Tumors.

Phase: N/A Priority: Normal
NCT ID: NCT05767060 Org: User:
Start: 01/20/22 End: 12/20/24 Due: 12/20/25

Comparative Study to Evaluate the Pharmacokinetics of BAT2306 vs Cosentyx® in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04711343 Org: User:
Start: 06/08/22 End: 06/05/23 Due: 06/05/24

Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8008 for Injection

Phase: N/A Priority: Normal
NCT ID: NCT05620017 Org: User:
Start: 11/30/22 End: 12/31/25 Due: 12/31/26

A Phase I Clinical Trial of BAT5906 Injection in Patients With Wet Age-related Macular Degeneration

Phase: N/A Priority: Normal
NCT ID: NCT04151212 Org: User:
Start: 10/30/18 End: 04/30/21 Due: 04/30/22

Evaluate the Pharmacokinetics of BAT2606 Injection in Healthy Chinese Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05576454 Org: User:
Start: 09/20/22 End: 06/19/23 Due: 06/19/24

BAT1308 Combined with Platinum-Based Chemotherapy± Bevacizumab for PDL1-Positive (CPS ≥1) Cervical Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06123884 Org: User:
Start: 12/13/23 End: 01/31/27 Due: 01/31/28

Clinical Study of the Safety and Efficacy of BAT5906 Injection

Phase: N/A Priority: Normal
NCT ID: NCT04772105 Org: User:
Start: 10/16/20 End: 11/06/23 Due: 11/06/24

A Randomized, Double-blind, Single-dose, Two-arm Parallel Study to Compare the Pharmacokinetics and Safety of BAT1806 Prefilled Subcutaneous Injection With RoActemra® in Healthy Chinese Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05968508 Org: User:
Start: 08/29/23 End: 10/08/24 Due: 10/08/25

Assessment of Safety and Preliminary Clinical Efficacy with BAT6005 in Advanced Malignant Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05116709 Org: User:
Start: 11/12/21 End: 09/23/24 Due: 09/23/25

BAT7104 in Patients With Advanced Solid Tumours

Phase: N/A Priority: Normal
NCT ID: NCT05200013 Org: User:
Start: 04/29/22 End: 06/25/24 Due: 06/25/25

Clinical Study on the Efficacy and Safety of BAT5906 Injection

Phase: N/A Priority: Normal
NCT ID: NCT05141994 Org: User:
Start: 08/26/20 End: 09/06/22 Due: 09/06/23

Clinical Trial of BAT8003 (for Injection) for Patients With Advanced Epithelial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03884517 Org: User:
Start: 03/15/19 End: 02/08/21 Due: 02/08/22

A Clinical Trial of BAT4406F Injection in Patients with Neuromyelitis Optica Spectrum Disorders

Phase: N/A Priority: Normal
NCT ID: NCT06044350 Org: User:
Start: 08/01/23 End: 05/31/26 Due: 05/31/27

Compare the Pharmacokinetics and Safety of BAT3306 Injection Versus KEYTRUDA® Administered in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT06111196 Org: User:
Start: 11/05/23 End: 06/11/24 Due: 06/11/25

Clinical Study of Stage IV Psoriasis in Children With Geleli

Phase: N/A Priority: Normal
NCT ID: NCT05803187 Org: User:
Start: 04/05/23 End: 10/31/24 Due: 10/31/25

Assessment of Safety and Preliminary Efficacy With BAT6021 in Solid Tumor Patients

Phase: N/A Priority: Normal
NCT ID: NCT05073484 Org: User:
Start: 10/29/21 End: 03/30/23 Due: 03/30/24

Comparative Study to Evaluate the Pharmacokinetics of BAT1806 vs Actemra® in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03606876 Org: User:
Start: 06/13/18 End: 07/17/19 Due: 07/17/20

A Study to Evaluate PK, Efficacy, and Safety of BAT3306 Plus Chemo and Compare With Keytruda®(EU/US) in Participants With IV nqNSCLC

Phase: N/A Priority: Normal
NCT ID: NCT06280196 Org: User:
Start: 07/19/24 End: 10/30/28 Due: 10/30/29

Comparative Study of BAT2206 With Stelara® in Patients With Moderate to Severe Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT04728360 Org: User:
Start: 07/06/21 End: 07/07/23 Due: 07/07/24

Assessment of Safety, Tolerability and Pharmacokinetics With BAT8010 for Injection in Advanced Malignant Solid Tumors Patients

Phase: N/A Priority: Normal
NCT ID: NCT05848466 Org: User:
Start: 02/10/23 End: 07/31/25 Due: 07/31/26

A Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of the Combination of BAT8008 With BAT1308 in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06341114 Org: User:
Start: 04/12/24 End: 07/28/26 Due: 07/28/27

BAT1308 in Combination With Platinum-containing Chemotherapy is Used for the First-line Treatment of Advanced or Recurrent dMMR Endometrial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06321068 Org: User:
Start: 04/09/24 End: 12/31/25 Due: 12/31/26

A Comparative Study of BAT1706 and EU Avastin® in Patients With Advanced Non Squamous Non Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03329911 Org: User:
Start: 10/20/17 End: 05/27/21 Due: 05/27/22

The Efficacy and Safety of BAT8001 Injection for the Treatment of HER2-positive Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04185649 Org: User:
Start: 07/01/18 End: 12/31/21 Due: 12/31/22